What is it about?
In the current era of precision/ personalized/ individualized medicine, metabolomics data sets from a single individual (n=1) is going to be a corner stone in health care in laboratory medicine practice. Beyond the realms of mass-spectometry for new born screening of those of Mendelian genetic disorders, advances and innovations in metabolomics hold promise for implementation in the near future. This opinion article discussed there opportunities and challenges.
Featured Image
Read the Original
This page is a summary of: Individualized metabolomics: opportunities and challenges, Clinical Chemistry and Laboratory Medicine (CCLM), April 2019, De Gruyter,
DOI: 10.1515/cclm-2019-0130.
You can read the full text:
Contributors
The following have contributed to this page







